Wave Life Sciences (WVE) News Today $8.62 -0.39 (-4.33%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$8.52 -0.09 (-1.10%) As of 03/28/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Wave Life Sciences Ltd. (NASDAQ:WVE) Position Increased by Swiss National BankSwiss National Bank raised its stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 33.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 208,800 shares of the company's stock after buying an additional 52,300 shares durMarch 28 at 3:30 AM | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Buy" from AnalystsWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has earned a consensus recommendation of "Buy" from the ten research firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has giMarch 28 at 2:08 AM | marketbeat.comWave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531March 27 at 4:14 PM | seekingalpha.comWave Life Sciences unveils Phase II data for DMD therapy, WVE-N531March 27 at 1:44 PM | finance.yahoo.comHC Wainwright Reaffirms Buy Rating for Wave Life Sciences (NASDAQ:WVE)HC Wainwright reiterated a "buy" rating and issued a $22.00 target price on shares of Wave Life Sciences in a research note on Wednesday.March 27 at 12:19 PM | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Gap Up - Here's WhyWave Life Sciences (NASDAQ:WVE) Shares Gap Up - Here's WhyMarch 27 at 10:49 AM | marketbeat.comWave Life Sciences shares surge on positive DMD trial resultsMarch 27 at 8:42 AM | investing.com68,927 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Purchased by Quantbot Technologies LPQuantbot Technologies LP purchased a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 68,927 shares of the company's stock, valued at approximately $853,000. SeveraMarch 27 at 4:06 AM | marketbeat.comWave Life Sciences' (WVE) "Buy" Rating Reaffirmed at HC WainwrightMarch 27 at 3:45 AM | americanbankingnews.comBRIEF-Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMDMarch 26 at 10:25 PM | sg.finance.yahoo.comWave to seek FDA accelerated approval for Duchenne candidate in 2026March 26 at 10:25 PM | msn.comAnalysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Wave Life Sciences (WVE)March 26 at 10:25 PM | markets.businessinsider.comWave Life Sciences announces data from Phase 2 FORWARD-53 trial of WVE-N531March 26 at 10:25 PM | markets.businessinsider.comWave Life Sciences (NASDAQ:WVE) Trading Down 5.3% - Here's What HappenedWave Life Sciences (NASDAQ:WVE) Trading Down 5.3% - Here's What HappenedMarch 26 at 5:12 PM | marketbeat.comWave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next YearMarch 26 at 11:00 AM | benzinga.comWave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531March 26 at 7:30 AM | globenewswire.comWave Life Sciences Ltd. (NASDAQ:WVE) Position Boosted by Emerald Advisers LLCEmerald Advisers LLC boosted its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 9.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,162,369 shares of the company's stock after acquiring an adMarch 24, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Director Christian O. Henry Sells 10,500 SharesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) Director Christian O. Henry sold 10,500 shares of the stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $9.77, for a total value of $102,585.00. Following the completion of the transaction, the director now directly owns 16,115 shares in the company, valued at approximately $157,443.55. This trade represents a 39.45 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.March 22, 2025 | marketbeat.comInsider Selling: Wave Life Sciences Ltd. (NASDAQ:WVE) Director Sells 10,500 Shares of StockMarch 22, 2025 | insidertrades.comCharles Schwab Investment Management Inc. Grows Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Charles Schwab Investment Management Inc. increased its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 914,469 shares of the companMarch 22, 2025 | marketbeat.comPrivium Fund Management B.V. Has $1.09 Million Stake in Wave Life Sciences Ltd. (NASDAQ:WVE)Privium Fund Management B.V. lifted its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 80.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 88,000 shares of the company's stocMarch 20, 2025 | marketbeat.comPlatinum Investment Management Ltd. Has $3.86 Million Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Platinum Investment Management Ltd. lessened its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 32.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 311,992 sMarch 20, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Acquired by Bank of New York Mellon CorpBank of New York Mellon Corp increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 21.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 244,973 shares of the company'sMarch 20, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA lessened its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 2.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,519,520 shares of the company's stock after selling 61,180March 19, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $4.80 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 19.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 387,871 shares of the company's stockMarch 17, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Up 13.1% - Still a Buy?Wave Life Sciences (NASDAQ:WVE) Stock Price Up 13.1% - Still a Buy?March 12, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) CEO Paul Bolno Sells 169,025 SharesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) CEO Paul Bolno sold 169,025 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $9.57, for a total value of $1,617,569.25. Following the completion of the sale, the chief executive officer now owns 338,351 shares of the company's stock, valued at approximately $3,238,019.07. This trade represents a 33.31 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.March 8, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Stock Price Down 6.1% - Here's What HappenedWave Life Sciences (NASDAQ:WVE) Trading Down 6.1% - Here's WhyMarch 8, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for WVE FY2025 Earnings?Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Stock analysts at HC Wainwright lowered their FY2025 earnings estimates for Wave Life Sciences in a report issued on Wednesday, March 5th. HC Wainwright analyst A. Fein now anticipates that the company will earn ($0.87) per share for the year,March 8, 2025 | marketbeat.comPaul Bolno Sells 169,025 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) StockMarch 8, 2025 | insidertrades.comB. Riley Reduces Earnings Estimates for Wave Life SciencesWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Investment analysts at B. Riley cut their Q1 2025 earnings per share estimates for Wave Life Sciences in a research note issued on Wednesday, March 5th. B. Riley analyst M. El-Saadi now anticipates that the company will earn ($0.28) per share fMarch 8, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Rating Increased to Hold at StockNews.comStockNews.com raised Wave Life Sciences from a "sell" rating to a "hold" rating in a report on Saturday.March 8, 2025 | marketbeat.comQ1 Earnings Estimate for WVE Issued By HC WainwrightWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Investment analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of Wave Life Sciences in a research note issued to investors on Wednesday, March 5th. HC Wainwright analyst A. Fein anticipates that the company will post eMarch 7, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Stock Price Down 6.1% - Should You Sell?Wave Life Sciences (NASDAQ:WVE) Stock Price Down 6.1% - Should You Sell?March 6, 2025 | marketbeat.comWave Life Sciences Ltd. (WVE) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comHC Wainwright Reiterates "Buy" Rating for Wave Life Sciences (NASDAQ:WVE)HC Wainwright restated a "buy" rating and issued a $22.00 price objective on shares of Wave Life Sciences in a report on Wednesday.March 6, 2025 | marketbeat.comB.Riley Financial Sticks to Its Buy Rating for Wave Life Sciences (WVE)March 5, 2025 | markets.businessinsider.comWave Life Sciences Ltd. (NASDAQ:WVE) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | msn.comWave Life Sciences (NASDAQ:WVE) Trading Up 5.4% on Strong EarningsWave Life Sciences (NASDAQ:WVE) Stock Price Up 5.4% Following Strong EarningsMarch 5, 2025 | marketbeat.com24,461 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Los Angeles Capital Management LLCLos Angeles Capital Management LLC bought a new stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 24,461 shares of the company's stock, valued at approximatelMarch 5, 2025 | marketbeat.comPrincipal Financial Group Inc. Buys Shares of 248,645 Wave Life Sciences Ltd. (NASDAQ:WVE)Principal Financial Group Inc. bought a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 248,645 shares of the company's stock, valued at approximately $3,076,00March 5, 2025 | marketbeat.comWave Life Sciences USA, Inc.: Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 4, 2025 | finanznachrichten.deWAVE LIFE SCIENCES Earnings Preview: Recent $WVE Insider Trading, Hedge Fund Activity, and MoreMarch 4, 2025 | nasdaq.comWave Life Sciences reports Q4 EPS 17c vs (15c) last yearMarch 4, 2025 | markets.businessinsider.comWave Life Sciences (NASDAQ:WVE) Issues Earnings Results, Beats Expectations By $0.35 EPSWave Life Sciences (NASDAQ:WVE - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.17 EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $0.35. Wave Life Sciences had a negative net margin of 66.50% and a negative return on equity of 280.57%.March 4, 2025 | marketbeat.comWave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 4, 2025 | globenewswire.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Wave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) have received a consensus recommendation of "Buy" from the ten research firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendaMarch 3, 2025 | marketbeat.comHandelsbanken Fonder AB Purchases New Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Handelsbanken Fonder AB purchased a new stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 50,800 shares of the company's stock, valued at approximatelMarch 2, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Upgraded to Hold at StockNews.comStockNews.com upgraded shares of Wave Life Sciences from a "sell" rating to a "hold" rating in a report on Thursday.February 28, 2025 | marketbeat.comWave Life Sciences (WVE) to Release Quarterly Earnings on WednesdayWave Life Sciences (NASDAQ:WVE) will be releasing earnings before the market opens on Wednesday, March 5, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=570913)February 26, 2025 | marketbeat.com Remove Ads Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address WVE Media Mentions By Week WVE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WVE News Sentiment▼0.760.79▲Average Medical News Sentiment WVE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WVE Articles This Week▼215▲WVE Articles Average Week Remove Ads Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TLX News BPMC News KRYS News NUVL News CYTK News VRNA News GRFS News ELAN News ADMA News PTCT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WVE) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wave Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
